Comparatively, the BRCA1 mutated UWB1.289 cancer cells demonstrated a much lower PARP1 and a reduced PARP2 mRNA transcription than the other ovarian cancer cell lines tested (t-test, p < 0.001). This evidence concerns the gene PARP2 and ovarian carcinoma.